● Recruiting

Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical Surgery

Condition: Non-small Cell Lung Cancer · Sponsor: Liaoning Cancer Hospital & Institute

PhaseN/A

Planned participants240

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

This study is a multicenter, prospective, and observational clinical study aimed at exploring whether the 3-year DFS in the Huaier group is not inferior to the control group receiving standard platinum dual-drug chemotherapy.

This description comes directly from the study's public registry record.

Talk to the study team

Hongxu Liu, PhD · +8618040097698 · hxliu@cmu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Liaoning Cancer Hospital & Institute

Shenyang, Liaoning, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06109454